Untreated Adult Acute Myeloid Leukemia Completed Phase 1 Trials for Imatinib (DB00619)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00025415Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver DysfunctionTreatment